Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A mathematical model for inflammation and demyelination in multiple sclerosis.
Modulation of TH17 cell activity by REV-ERB agonists: path toward novel treatments for canine meningoencephalitis of unknown origin.
Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples.
All anti-CD20 therapies are equivalent in treating MS-YES.
A novel small molecule remyelination therapy for multiple sclerosis.
A ketamine/methionine exposure paradigm, alone or combined with Lactobacillus rhamnosus GG, assessing schizophrenia-relevant behavioral, oxidative stress, and molecular endpoints in adult zebrafish.
Current advances and future perspectives of Astragalus membranaceus active components in regulating diabetic microvascular complications.
Ultrastructure of the somatic motor system in Bothrops jararaca (Reptilia, Squamata, Viperidae).
Network dynamics under neuronal degradation: A comparison between modular and small-world topologies.
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review.
Potential benefits of music-based therapies on rehabilitation outcomes in people with multiple sclerosis: a systematic review.
Comprehensive Analysis of Ozanimod-Related Adverse Events Based on the FAERS Database.
A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.
"All anti-CD20 therapies are equivalent in treating MS": Commentary.
All anti-CD20 therapies are equivalent in treating MS: No.
Intravenous placenta-derived mesenchymal stem cells enhance early survival as an adjunct to supportive care in severe burn: a preclinical study.
Steroid-dependent regulation of central nervous system remyelination: From gonadal hormones to chemokine signaling.
Chronic lead exposure disrupts copper redox homeostasis and aggravates neurodegeneration.
Autoimmune nodopathies: a clinical review.
Spatial Transcriptomic Decoupling and Magnetic Resonance Imaging Identify the Genetic and Cytoarchitectonic Correlates of Regional Vulnerability in Alzheimer's Disease.
Comparative Analysis of Choroid Plexus Volume Between MOG Antibody Associated Disease and Multiple Sclerosis.
The E3 Ubiquitin Ligase RLIM Safeguards Oligodendrocyte Development and Myelination by Targeting SLC7A11 for Polyubiquitination to Regulate Ferroptotic Resistance.
F-box and WD repeat domain-containing 7 promotes nerve regeneration to exert therapeutic protection against preterm brain injury by degrading Notch receptor 1.
Ocrelizumab-induced colitis acutely managed with ciclosporin.
The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications.
Pages
« first
‹ previous
…
1042
1043
1044
1045
1046
1047
1048
1049
1050
next ›
last »